Stella Pharma Corporation

Tokyo Stock Exchange 4888.T

Stella Pharma Corporation Market Capitalization on January 14, 2025: USD 107.24 M

Stella Pharma Corporation Market Capitalization is USD 107.24 M on January 14, 2025, a 11.89% change year over year. Market capitalization represents total company value in stock market; higher suggests larger, more established company.
  • Stella Pharma Corporation 52-week high Market Capitalization is USD 134.67 M on October 01, 2024, which is 25.57% above the current Market Capitalization.
  • Stella Pharma Corporation 52-week low Market Capitalization is USD 77.18 M on August 05, 2024, which is -28.03% below the current Market Capitalization.
  • Stella Pharma Corporation average Market Capitalization for the last 52 weeks is USD 113.48 M.
Key data
Date Market Capitalization Share Price Price to Earnings Ratio (P/E) Price to Sales Ratio (P/S)
Market news
Tokyo Stock Exchange: 4888.T

Stella Pharma Corporation

CEO Mr. Koki Uehara
IPO Date April 22, 2021
Location Japan
Headquarters ORIX Kouraibashi Building
Employees 44
Sector Health Care
Industries
Pharmaceuticals Biotechnology
Description

Stella Pharma Corporation engages in the research, development, manufacturing, and distribution of pharmaceuticals. The company develops drugs for boron neutron capture therapy (BNCT). Its product includes SPM-011, a boron-containing drug for BNCT used for treating head and neck cancer, recurrent malignant glioma and meningioma, and malignant melanoma and angiosarcoma. The company was incorporated in 2007 and is headquartered in Osaka, Japan.

StockViz Staff

January 15, 2025

Any question? Send us an email